Ignite Creation Date:
2024-05-06 @ 11:03 AM
Last Modification Date:
2024-10-26 @ 12:39 PM
Study NCT ID:
NCT03420222
Status:
TERMINATED
Last Update Posted:
2022-05-24
First Post:
2018-01-19
Brief Title:
Study to Assess the Efficacy Safety and Tolerability of AVP-786 for the Treatment of Intermittent Explosive Disorder
Sponsor:
Otsuka Pharmaceutical Development Commercialization Inc
Organization:
Otsuka Pharmaceutical Development Commercialization Inc
Organization Data
Organization:
Otsuka Pharmaceutical Development Commercialization Inc
Class:
INDUSTRY
Study ID:
17-AVP-786-206
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Otsuka Pharmaceutical Development Commercialization Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None